Adenosine Phosphate

Adenosine Phosphate

SCHEMBL3828789

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3

The experimentally established mechanism targets of Adenosine Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 known ✓ P30542 3/20 0.92
ADORA3 known ✓ P0DMS8 1/20 0.77
ADORA2A known ✓ P29274 1/20 0.77
ADORA2B known ✓ P29275 1/20 0.77
P2RY1 P47900 5/20 0.92
P2RY2 P41231 3/20 0.92
SMN1; SMN2 Q16637 3/20 0.92
SRC P12931 2/20 0.92
TRPM2 O94759 2/20 0.92
TAS1R3 Q7RTX0 2/20 0.92
TAS1R1 Q7RTX1 2/20 0.92
DNPH1 O43598 1/20 0.92
PRKAB2 O43741 1/20 0.92
LDHA P00338 1/20 0.92
ADRB2 P07550 1/20 0.92
FBP1 P09467 1/20 0.92
PRKAG1 P54619 1/20 0.92
PRKAA2 P54646 1/20 0.92
PDE4D Q08499 1/20 0.92
KCNH2 Q12809 1/20 0.92

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vidarabine Phosphate SCHEMBL7111227 0.99 P2RY1 (0.90) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL290977 0.99 P2RY1 (0.90) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL144997 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL8572634 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL20277555 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL1338615 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL132458 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL19420134 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL13170051 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC
Adenosine Phosphate SCHEMBL11977309 0.96 P2RY1 (1.00) P2RY1P2RY2SMN1; SMN2ADORA1SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023249425-A1 FUSION PROTEIN COMPRISING ANTI-CD73 ANTIBODY AND IL-2, AND USE THEREOF ㈜지아이이노베이션 2023-12-28 WO disclosed
CN-112779260-B Aptamer of flavin mononucleotide, screening method and application thereof 中国科学院苏州纳米技术与纳米仿生研究所 2022-08-26 CN disclosed
US-20210393856-A1 COMPOSITIONS AND METHODS FOR REDUCING CALCIFICATION OF HEART VALVES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2021-12-23 US disclosed
CN-113423418-A Treatment of cilia disease 埃泽瑞斯公司 2021-09-21 CN disclosed
CN-112779260-A Aptamer of flavin mononucleotide, screening method and application thereof 中国科学院苏州纳米技术与纳米仿生研究所 2021-05-11 CN disclosed
CN-111671007-A Pomegranate seeds as feed additive for improving pork quality and flavor and application thereof 浙江省农业科学院 2020-09-18 CN disclosed
EP-3701051-A1 SELECTION AND USE OF MELATONIN SUPPORTING BACTERIA TO REDUCE INFANTILE COLIC Biogaia AB (SE) 2020-09-02 EP disclosed
CN-111378705-A Method for preparing adenine and D-ribose by hydrolyzing adenosine with adenosine hydrolase 通辽德胜生物科技有限公司 2020-07-07 CN disclosed
CN-111362945-A Method for synthesizing adenine by adenosine hydrolysis method 洛阳德胜生物科技股份有限公司 2020-07-03 CN disclosed
WO-2020068951-A1 COMPOSITIONS AND METHODS FOR REDUCING CALCIFICATION OF HEART VALVES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2020-04-02 WO disclosed
WO-1999037151-A1 METHOD AND COMPOSITIONS FOR PROMOTION OF WOUND HEALING BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1999-07-29 WO disclosed
WO-1999032605-A1 METHOD FOR PRODUCING HETEROLOGOUS PROTEINS IN EUKARYOTIC CELLS ON AN INDUSTRIAL SCALE USING NUCLEOTIDE-MANIPULATING AGENTS NOVO NORDISK A/S (DK) 1999-07-01 WO disclosed
WO-1999023214-A1 COMPOSITIONS AND METHODS FOR ENHANCING CARDIAC CONTRACTILITY MEDIATED BY MYOCYTE P2 PURINOCEPTORS AND MODELS THEREOF THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 1999-05-14 WO disclosed
WO-1999007877-A1 BIOSENSOR FOR DETECTING ADENOSINE THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) 1999-02-18 WO disclosed
US-5712256-A WOUND HEALING, YEASTS, ADENIN OR ADENOSINE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 1998-01-27 US disclosed
EP-0302807-B1 Food products enriched with nucleosides and/or nucleotides and preparation thereof PULEVA UNION IND AGRO GANADERA (ES) 1994-01-19 EP disclosed
US-5227371-A Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations RAPAPORT ELIEZER (US) 1993-07-13 US disclosed
EP-0415018-A1 Utilization of adenine nucleotides and/or adenosine and inorganic phosphate for elevation of liver, blood and blood plasma adenosine 5'-triphosphate concentrations Rapaport, Eliezer (US) 1991-03-06 EP disclosed
WO-1987007531-A1 ENDOTOXIN REMOVAL ROYAL POSTGRADUATE MEDICAL SCHOOL (GB) 1987-12-17 WO disclosed
US-4650752-A ELECTROCHEMICAL, RAPID, ACCURATE ORIENTAL YEAST CO. LTD. (JP) 1987-03-17 US disclosed